Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

333
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
333
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

955
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
955

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Common Salivary Protein 1 in Saliva of Diabetes Patients (II).

Clinical laboratory·2020
Same author

Treacher Collins syndrome: Clinical report and retrospective analysis of Chinese patients.

Molecular genetics & genomic medicine·2020
Same author

Co-Delivery of <sup>131</sup> I and Prima-1 by Self-Assembled CD44-Targeted Nanoparticles for Anaplastic Thyroid Carcinoma Theranostics.

Advanced healthcare materials·2020
Same author

Bisphenol A attenuates testosterone production in Leydig cells via the inhibition of NR1D1 signaling.

Chemosphere·2020
Same author

Quantitation of ultra-trace nitrated polycyclic aromatic hydrocarbons isomers in water by online solid-phase extraction coupled-liquid chromatography-mass spectrometry.

Journal of chromatography. A·2020
Same author

Pathogenic variants identified by whole-exome sequencing in 43 patients with epilepsy.

Human genomics·2020

相关实验视频

Updated: Jun 15, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

反事实偏差共嵌入模型用于增强药物相互作用预测.

Xue Pan1, Chunping Ouyang1, Linlin Zhang2

  • 1School of Computer Science, University of South China, Hengyang, China.

Journal of computational biology : a journal of computational molecular cell biology
|June 13, 2025
PubMed
概括

预测药物相互作用对药物安全至关重要. 一个新的反事实性无基因共嵌入 (CDCE) 模型有效地整合了药物特性和网络数据,优于DDI预测的现有方法.

关键词:
分配给网络的网络.这是一个反事实性的反事实.药物 药物相互作用网络嵌入 网络嵌入变量自动编码器变量自动编码器

更多相关视频

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

相关实验视频

Last Updated: Jun 15, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

科学领域:

  • 药理学和化学信息学
  • 计算机化药物发现技术

背景情况:

  • 预测药物相互作用 (DDI) 对患者安全和药物开发至关重要.
  • 目前的DDI预测方法经常与稀疏的相互作用数据和药物特性有限的整合作斗争.

研究的目的:

  • 开发一种新型的共同嵌入模型,反事实性 debiased 共同嵌入 (CDCE),以改善 DDI 预测.
  • 为应对稀疏的DDI网络和嵌入过程中的信息丢失所带来的挑战.

主要方法:

  • 实施了反事实性退市方法,以减轻网络稀疏性和嵌入损失.
  • 融合解剖治疗化学 (ATC) 代码和简化分子输入线输入系统 (SMILES) 药物属性.
  • 使用变量图形自编码器在DDI网络中集成ATC和SMILES信息.

主要成果:

  • 与BioSNAP数据集上最先进的方法相比,CDCE模型显示出更高的性能.
  • 成功地整合了各种药物属性信息,以提高预测准确度.
  • 缓解了与稀疏的DDI网络和信息嵌入相关的问题.

结论:

  • 通过有效地结合网络拓和药物属性,CDCE为准确的DDI预测提供了一个强大的框架.
  • 反事实性脱债策略在数据稀缺的场景中提高模型性能.
  • 这种方法推进了计算方法,以确保药物在发现和开发中的安全性.